Trial intelligence / Profile preview

Effects of tastant on salivation flow

jRCT1060210036Recruiting

Sponsor
Okayama University Hospital
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of monosodium inosinate in xerostomia, sponsored by Okayama University Hospital. Primary endpoint: Changes in saliva flow over time. Started Oct 2021; status: recruiting.

02

Drugs

monosodium inosinate
03

Conditions

xerostomia

Beyond the preview

Go deeper on jRCT1060210036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1060210036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call